Press Release TIVDAK® Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer 9 January 2024
Press Release TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer 9 January 2024
Press Release Spire Global to Launch the First Commercial Space Situational Awareness Satellite Constellation for NorthStar Earth & Space 9 January 2024
Press Release Mitsubishi Electric US, Inc. Announces Launch of AnyMile™ Drone-based Logistics Operations Management Platform 9 January 2024
Press Release Ault Alliance Returns to Treasury Common and Preferred Stock, Enhancing Financial Stability 9 January 2024
Press Release Spring Valley Acquisition Corp. II Announces Preliminary Redemption Results 9 January 2024
Press Release Stellus Capital Management, LLC Provides Unitranche Financing in Support of Summit Park’s Acquisition of Michelli Weighing & Measurement 9 January 2024
